Skip to content
Review

India’s medical device regulatory framework: a decade of transformation, international harmonization, and the road to global competitiveness

Oct 2026 · Expert Review of Medical Devices · Vol 23, pp. 1245 - 1259 · 0 citations · 59 references
Medicine

Abstract

ABSTRACT Introduction India’s medical device regulatory landscape has undergone fundamental transformation over the past decade, with the Medical Device Rules (MDR) 2017 establishing the country’s first purpose-built, risk-stratified regulatory architecture. This review examines that decade of reform to assess India’s progress toward international regulatory harmonization and to identify priorities for further development. Areas covered This structured narrative review traces legislative and institutional development from the Drugs and Cosmetics Act 1940 through five MDR 2017 amendments to 2024, benchmarks India’s framework against the US FDA, EU MDR 2017/745, and the WHO Global Model Framework across ten regulatory domains, and assesses the regulatory–industrial nexus through the PLI scheme, Medical Device Parks, and NMDP 2023. A structured search of PubMed, ScienceDirect, and SpringerLink (2014–2024) was supplemented by gazette notifications, CDSCO guidance, and ministry and parliamentary publications. Expert opinion India’s reforms have generated measurable advances in device quality, patient safety, and affordability, positioning the framework substantively – though not fully – on par with leading global regulators, with persisting gaps in enforcement capacity, AI/ML governance, and device-data integration. Closing these gaps over the next 5 years should bring India’s framework into closer alignment with IMDRF reference members. GRAPHICAL ABSTRACTInfographic: Indias Medical Device Regulatory Framework: A Decade of Transformation. Timeline (2017-2024): MDR 2017 Foundation, Risk Classification A to D. Amendments: 2018 - Fast-track pathways; AIR mandate. 2020 - Universal coverage; PSURs. 2021 - IVD matrix; companion diagnostics. 2023 - SaMD; AI/ML; cybersecurity. 2024 - 3D-printed implants; sustainability. Strategic pillars: Regulatory Architecture - CDSCO, MDR 2017; MvPI Surveillance; UDI Traceability; ISO 13485 QMS. Industrial Policy - PLI Scheme ($460M); AMTZ, Device Parks; NMDP 2023; Make in India. Technology Frontier - SaMD, AI/ML Devices; 3D-Printed Implants; Cybersecurity Standards; Digital Health, ABDM. Outcomes: Market Share Growth from 10% to 30% Domestic Share. Adverse Events Monitored: >3,000/year MvPI Reports. Beneficiaries: 550M+ PM-JAY. IMDRF Aligned: Full Framework Harmonization. Remaining gaps: Enforcement Gaps; Incomplete UDI Roll-out; AI/ML Governance Maturity; Innovation-Affordability Balance.An infographic on Indias medical device regulatory transformation, 2017 to 2024.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.